Effects of Protein Tyrosine Phosphatase Inhibitors on EGF- and Insulin-Dependent Mammary Epithelial Cell Growth

Experimental Biology and Medicine

Volumn 217, Issue 2, 1998, Pages 180-187

  McIntyre, Barry S ^a   Briski, Karen P ^a   Hosick, Howard L ^a   Sylvester, Paul W ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; INSULIN; PROTEIN TYROSINE KINASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE; VANADIC ACID;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GROWTH REGULATION; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIVISION; CELLS, CULTURED; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FEMALE; INSULIN; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED BALB C; PHOSPHOTYROSINE; PROTEIN-TYROSINE-PHOSPHATASE; TETRADECANOYLPHORBOL ACETATE; VANADATES;

EID: 0031943946     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-217-44221     Document Type: Article

References (42)

1. Jove R, Hanafusa H. Cell transformation by the viral src oncogene. Ann Rev Cell Dev Biol 3:31-56, 1987.
2. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212, 1990.
3. Hunter T. Protein modification: Phosphorylation on tyrosine residues. Curr Opin Cell Biol 1:1168-1181, 1989.
4. Fischer EH, Charbonneau H, Tonks NK. Protein tyrosine phosphatases: A diverse family of intracellular and transmembrane enzymes. Science 253:401-406, 1991.
5. Walton KM, Dixon JE. Protein tyrosine phosphatases. Annu Rev Biochem 62:101-120, 1993.
6. Zhang Z-Y, Dixon JE. Protein tyrosine phosphatases: Mechanism of catalysis and substrate specificity. Adv Enzymol Relat Areas Mol Biol 68:1-36, 1994.
7. Klarlund JK. Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins. Cell 41:707-717, 1985.
8. Maher PA. Stimulation of endothelial cell proliferation by vanadate is specific for microvascular endothelial cells. J Cell Physiol 151:549-554, 1992.
9. Sabbioni E, Pozzi G, Pintar A, Casella L, Garattini S. Cellular retention, cytotoxicity and morphological transformation by vanadium (IV) and vanadium (V) in BALB/3T3 cell lines. Carcinogenesis 12:47-52, 1991.
10. Kowalski TE, Tsang S-S, Davison AJ. Vanadate enhances transformation of bovine papillomavirus DNA-transfected C3H/10T1/2 cells. Cancer Lett 64:83-90, 1992.
11. Faure R, Vincent M, Dufour M, Shaver A, Posner BI. Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: Studies on a neuronal and a glial cell line. J Cell Biochem 59:389-401, 1995.
12. Morla AO, Draetta G, Beach D, Wang JYJ. Reversible tyrosine phosphorylation of cdc2: Dephosphorylation accompanies activation during entry into mitosis. Cell 58:193-203, 1989.
13. Stern A, Yin X, Tsang S-S, Davison A, Moon J. Vanadium as a modulator of cellular regulatory cascades and oncogene expression. Biochem Cell Biol 71:103-112, 1993.
14. Kadota S. Fantus IG, Deragon G, Guyda HJ, Hersh B, Posner BI. Peroxide(s) of vanadium: A novel and potent insulin-mimetic agent which activates the insulin receptor kinase. Biochem Biophys Res Commun 147:259-266, 1987.
15. Faure R, Baquiran G, Bergeron JJ, Posner BI. The dephosphorylation of insulin and epidermal growth factor receptors. J Biol Chem 267:11215-11221, 1992.
16. Evans GA, Garcia GG, Erwin R, Howard OM, Farrar WL. Pervana-date stimulates the effects of interleukin-2 (IL-2) in human T-cells and provides evidence for the activation of two distinct tyrosine kinase pathways by IL-2. J Biol Chem 269:23407-23412, 1994.
17. Huyer G, Lui S, Kelly J, Moffat J, Payette P, Kennedy B, Tsaprailis G, Gresser MJ, Ramachandran C. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem 272:843-851, 1997.
18. Cantley LC Jr., Aisen P. The fate of cytoplasmic vanadium: Implications on (Na,K)-ATPase inhibition. J Biol Chem 254:1781-1784, 1979.
19. Crans DC, Bunch R, Theisen LA. Interaction of trace levels of vana dium(IV) and vanadium(V) in biological systems. Journal of the American Chemical Society 111:7597-7607, 1989.
20. Leighton B, Cooper GJ, Da Costa C, Foot EA. Peroxovanadates have full insulin-like effects on glycogen synthesis in normal and insulin-resistant skeletal muscle. Biochem J 276:289-292, 1991.
21. 2 and vanadate stimulate tyrosine phosphorylation of potential targets for the insulin receptor kinase in intact cells. Biochem J 288:631-635, 1992.
22. Shisheva A, Shechter Y. Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: Dissociation from the vanadate effect. Endocrinology 133:1562-1568, 1993.
23. Fantus IG, Kadota S, Deragon G, Foster B, Posner BI. Pervanadate (peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry 28:8864-8871, 1989.
24. Cortizo AM, Etcheverry SB. Vanadium derivatives act as growth factor-mimetic compounds upon differentiation and proliferation of osteoblast-like UMR106 cells. Mol Cell Biochem 145:97-102, 1995.
25. Raid A, Oliver B, Abdelrehman A, Sha'afi RI, Hajjar J-J. Role of tyrosine kinase and phosphotyrosine phosphatase in growth of intestinal crypt cell (IEC-6) line. Proc Soc Exp Biol Med 202:435-439, 1993.
26. Imagawa W, Tomooka Y, Nandi S. Serum-free growth of normal and tumor mouse mammary epithelial cells in primary culture. Proc Natl Acad Sci USA 79:4074-4077, 1982.
27. Imagawa W, Bandopadhyay GK, Nandi S. Regulation of mammary epithelial cell growth in mice and rats, Endocrine Rev 11:494-523, 1990.
28. Nicholson RI, McClelland, Finlay P, Eaton CL, Gullick WJ, Dixon AR, Robertson JFR, Ellis IO, Blarney RW. Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity. Eur J Cancer 29:1018-1023, 1993.
29. Dougall WC, Qian X, Greene MI. Interaction of the neu/p185 and EGF receptor tyrosine kinases: Implications for cellular transformation and tumor therapy. J Cell Biochem 53:61-73, 1993
30. Peles E, Yarden Y. Neu and its ligands: From an oncogene to neural factors. Bioessays 15:815-824, 1993.
31. Sylvester PW, Birkenfeld HP, Hosick HL, Briski KP. Fatty acid modu lation of epidermal growth factor-induced mouse mammary epithelial cell proliferation in vitro. Exp Cell Res 214:145-153, 1994.
32. Yang J, Richards J, Bowman P, Guzman R, Enami J, McCormick K, Hamamoto S, Pitelka D, Nandi S. Sustained growth and three-dimensional organization of primary mammary tumor epithelial cells embedded in collagen gels. Proc Natl Acad Sci USA 76:3401-3405, 1979.
33. Jones W, Hallowes RC, Choongkittaworn N, Hosick HL, Oils R. Isolation of the epithelial subcomponents of the mouse mammary gland for tissue-level culture studies. Journal of Tissue Culture Methods 8:17-25, 1983.
34. McIntyre BS, Birkenfeld HP, Sylvester PW. Relationship between epidermal growth factor receptor levels, autophosphorylation and mitogenic -responsiveness in normal mouse mammary epithelial cells in vitro. Cell Prolif 28:45-56, 1995.
35. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979.
36. Kanazawa T, Hosick HL. Transformed growth phenotype of mouse mammary epithelium in primary culture induced by specific fetal mesenchymes. J Cell Physiol 153:381-391, 1992.
37. Burke TR. Protein-tyrosine kinase inhibitors. Drugs of the Future 17:119-131, 1992.
38. Chen Y, Chan TM. Orthovanadate and 2,3,-dimethoxy-1,4,naphthoquinone augment growth factor-induced cell proliferation and c-fos gene expression in 3T3-L1 cells. Arch Biochem Biophys 305:9-16, 1993.
39. Yin X, Davison AJ, Tsang S-S. Vanadate-induced gene expression in mouse C127 cells: Roles of oxygen derived active species. Mol Cell Biochem 115:85-96, 1992.
40. Weinberg RA. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 49:3713-3721, 1989.
41. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SO, Keith DE, Levin WJ, Stuart SO, Udove J, Ullrich A, Press MF. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712, 1989.
42. McGeady ML, Kerby S, Shankar V, Ciardiello F, Salomon DS, Seidman M. Infection with TGF-α retroviral vector transforms normal mouse mammary epithelial cells but not normal rat fibroblasts. Oncogene 4:1375-1382, 1989.